Publications by authors named "Martee L Hensley"

100Publications

Secondary surgical resection for patients with recurrent uterine leiomyosarcoma.

Gynecol Oncol 2019 08 12;154(2):333-337. Epub 2019 Jun 12.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.05.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650305PMC
August 2019

Reply to F. Tomao et al.

J Clin Oncol 2019 04 27;37(11):936. Epub 2019 Feb 27.

Martee L. Hensley, MD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Danielle Enserro, PhD, Roswell Park Comprehensive Cancer Center, Buffalo, NY; and David S. Miller, MD, The University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.02063
Publisher Site
http://dx.doi.org/10.1200/JCO.18.02063DOI Listing
April 2019

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.

Gynecol Oncol 2019 02 22;152(2):251-258. Epub 2018 Nov 22.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613945PMC
February 2019

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2018 Oct 5:JCO1800454. Epub 2018 Oct 5.

Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Martee L. Hensley and Oliver Zivanovic, Weill Cornell Medical College, New York City; Danielle Enserro and Shashikant B. Lele, Roswell Park Comprehensive Cancer Center, Buffalo, NY; Helen Hatcher, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge; Cyril Fisher, University of Birmingham, Birmingham, United Kingdom; Petronella B. Ottevanger, Radboud University Medical Center, Nijmegen, the Netherlands; Anders Krarup-Hansen, University Hospital Copenhagen, Copenhagen, Denmark; Jean-Yves Blay, Centre Leon Berard, Lyon, France; Katherine M. Moxley, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Jayanthi S. Lea, and David S. Miller, The University of Texas Southwestern Medical Center, Dallas, TX; Krishnansu S. Tewari, University of California at Irvine, Orange, CA; Premal H. Thaker, Washington University School of Medicine, and Siteman Cancer Center, St Louis, MO; David M. O'Malley, The Ohio State University College of Medicine, Columbus, OH; Katina Robison, Women and Infants Hospital in Rhode Island, Providence, RI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00454
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241678PMC
October 2018

Options for Adjuvant Therapy for Uterine Leiomyosarcoma.

Curr Treat Options Oncol 2018 02 8;19(2). Epub 2018 Feb 8.

Memorial Sloan Kettering Cancer Center, 300 E. 66th Street, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-018-0526-0DOI Listing
February 2018

Soft Tissue and Uterine Leiomyosarcoma.

J Clin Oncol 2018 01 8;36(2):144-150. Epub 2017 Dec 8.

Suzanne George, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; César Serrano, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Martee L. Hensley, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY; and Isabelle Ray-Coquard, Centre Leon Berard and University Claude-Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.9845DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759317PMC
January 2018

Difficult Choices in Stage I Uterine Leiomyosarcoma- it's okay to "stand there".

Authors:
Martee L Hensley

Gynecol Oncol 2017 10;147(1):1-2

Gynecologic Medical Oncology, Memorial Sloan Kettering Cancer Center, 300 E. 66(th) Street, office 1355, New York, NY 10065; Weill Cornell Medical College, 300 E. 66(th) Street, office 1355, New York, NY 10065. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.09.004DOI Listing
October 2017

YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.

Gynecol Oncol 2017 06 5;145(3):531-535. Epub 2017 Apr 5.

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.03.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471810PMC
June 2017

Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Am J Surg Pathol 2017 01;41(1):12-24

*Department of Pathology, Memorial Sloan Kettering Cancer Center ‡Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY †Department of Pathology, Cork University Hospital, Wilton, Cork, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630222PMC
January 2017

A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Int J Gynecol Cancer 2016 Feb;26(2):255-60

Departments of *Medicine and †Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY; ‡Sanofi Statistics Department, Cambridge MA; and §Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009457PMC
February 2016

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

What Do You Say When She Is No Longer Living With Cancer?

Authors:
Martee L Hensley

J Clin Oncol 2015 Nov 10;33(31):3668-9. Epub 2015 Aug 10.

From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4105DOI Listing
November 2015

Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.

Neoplasia 2015 Feb;17(2):183-9

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2014.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351299PMC
February 2015

Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.

J Clin Oncol 2015 Apr 23;33(10):1180-5. Epub 2015 Feb 23.

Martee L. Hensley, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York; Austin Miller, NRG Oncology, Buffalo, NY; David M. O'Malley, The Ohio State University, Columbus, OH; Robert S. Mannel, University of Oklahoma, Oklahoma City, OK; Kian Behbakht, University of Colorado Denver, Aurora, CO; Jamie N. Bakkum-Gamez, Mayo Clinic, Rochester, MN; and Helen Michael, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.3781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372854PMC
April 2015

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S61-6

*Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY; †Mayo Clinic, Rochester, MN, GOG; ‡Gynäkologische Endokrinologie und Onkologie Universitätsklinikum Gießen und Marburg GmbH, AGO; §Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, RTOG; ∥Peter MacCallum Cancer Centre, Royal Women's Hospital, University of Melbourne, Melbourne, Australia, ANZOG; ¶Seoul National University College of Medicine, KGOG; #University of Tampere, Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland, NSGO; **Institut Gustave-Roussy, Villejuif, France, GINECO; ††NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, Glasgow, Scotland, SGCTG; ‡‡Academic Medical Center, Amsterdam, Netherlands, DGOG; §§Centre Léon Bérard, Lyon, GINECO.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830912PMC
November 2014

Management of advanced uterine leiomyosarcoma.

Curr Opin Oncol 2014 Jul;26(4):422-7

aDepartment of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center bWeill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000094DOI Listing
July 2014

Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials.

J Clin Oncol 2014 Feb 13;32(6):519-26. Epub 2014 Jan 13.

David M. Hyman, Anne A. Eaton, Mrinal M. Gounder, Erika G. Pamer, Martee L. Hensley, David R. Spriggs, and Alexia Iasonos, Memorial Sloan-Kettering Cancer Center; David M. Hyman, Mrinal M. Gounder, Martee L. Hensley, David R. Spriggs, and Alexia Iasonos, Weill Cornell Medical College, New York, NY; and Gary L. Smith and Percy Ivy, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.8808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918535PMC
February 2014

Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.

Int J Gynecol Cancer 2013 Nov;23(9):1635-41

*Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; ‡Department of Epidemiology and Biostatistics, and §Department of Gynecologic Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000001DOI Listing
November 2013

Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.

Int J Gynecol Cancer 2013 Nov;23(9):1620-8

*Gynecology Service, Department of Surgery, †Department of Pathology, and ‡Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY; §Weill Cornell Medical College, New York, NY; ∥Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and ¶Department of Pathology and Molecular Genetics and Research Laboratory, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLLEIDA, Lleida, Spain.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0b013e3182a5055eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405774PMC
November 2013

Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees.

Gynecol Oncol 2013 Sep 14;130(3):452-6. Epub 2013 Jun 14.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748179PMC
September 2013

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

Cancer 2013 Apr 18;119(8):1555-61. Epub 2013 Jan 18.

Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27942
Publisher Site
http://dx.doi.org/10.1002/cncr.27942DOI Listing
April 2013

Management of uterine adenosarcomas with and without sarcomatous overgrowth.

Gynecol Oncol 2013 Apr 30;129(1):140-4. Epub 2012 Dec 30.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258120099
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2012.12.036DOI Listing
April 2013

Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution.

Int J Gynecol Cancer 2012 Nov;22(9):1527-31

Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31827057e8DOI Listing
November 2012

High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.

Gynecol Oncol 2012 Oct 26;127(1):27-31. Epub 2012 Jun 26.

Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.06.030DOI Listing
October 2012

Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.

Gynecol Oncol 2012 May 21;125(2):409-13. Epub 2012 Feb 21.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082581200140
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2012.02.014DOI Listing
May 2012

Uterine sarcomas: histology and its implications on therapy.

Authors:
Martee L Hensley

Am Soc Clin Oncol Educ Book 2012 :356-61

From the Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.7DOI Listing
April 2016

Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.

Gynecol Oncol 2012 Apr 21;125(1):99-102. Epub 2011 Nov 21.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.11.020DOI Listing
April 2012

A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.

Gynecol Oncol 2012 Jan 13;124(1):48-52. Epub 2011 Oct 13.

Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.09.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497524PMC
January 2012

Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study.

Cancer 2012 May 20;118(9):2403-10. Epub 2011 Sep 20.

Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26569DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245795PMC
May 2012

Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.

Authors:
Martee L Hensley

Best Pract Res Clin Obstet Gynaecol 2011 Dec 14;25(6):773-82. Epub 2011 Jul 14.

Memorial Sloan-Kettering Cancer Center, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpobgyn.2011.06.003DOI Listing
December 2011

Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.

Gynecol Oncol 2011 May 26;121(2):319-22. Epub 2011 Jan 26.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.12.363DOI Listing
May 2011

Cognitive functions in long-term survivors of ovarian cancer.

Gynecol Oncol 2010 Nov 14;119(2):366-9. Epub 2010 Jul 14.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.06.023DOI Listing
November 2010

Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas.

Authors:
Martee L Hensley

Curr Opin Oncol 2010 Jul;22(4):356-61

Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2010/07000/Update_o
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32833aafefDOI Listing
July 2010

A step forward for two-step screening for ovarian cancer.

Authors:
Martee L Hensley

J Clin Oncol 2010 May 5;28(13):2128-30. Epub 2010 Apr 5.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.26.6346
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.26.6346DOI Listing
May 2010

Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratoma.

Gynecol Oncol 2010 May 7;117(2):382-4. Epub 2010 Feb 7.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.01.017DOI Listing
May 2010

Optimal management of uterine leiomyosarcoma.

Expert Rev Anticancer Ther 2010 Feb;10(2):153-69

Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.09.187DOI Listing
February 2010

Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.

Gynecol Oncol 2010 Mar 24;116(3):424-9. Epub 2009 Nov 24.

Department of Medicine, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.10.064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852374PMC
March 2010

Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.

Gynecol Oncol 2009 Mar 9;112(3):563-7. Epub 2009 Jan 9.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.11.027DOI Listing
March 2009

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.

Gynecol Oncol 2008 Nov 27;111(2):249-54. Epub 2008 Aug 27.

Memorial Sloan-Kettering Cancer Center Department of Medicine, Gynecologic Medical Oncology Service, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.06.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952566PMC
November 2008

What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?

Gynecol Oncol 2008 Oct 26;111(1):46-8. Epub 2008 Jul 26.

Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.06.010DOI Listing
October 2008

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

Gynecol Oncol 2008 Jun 18;109(3):323-8. Epub 2008 Apr 18.

Memorial Sloan-Kettering Cancer Center, Department of Medical Oncology, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.02.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692926PMC
June 2008

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.

Invest New Drugs 2007 Aug 16;25(4):335-41. Epub 2007 Mar 16.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-007-9035-xDOI Listing
August 2007

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.

J Clin Oncol 2007 Mar 29;25(9):1082-8. Epub 2007 Jan 29.

Developmental Chemotherapy Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.08.7304DOI Listing
March 2007

The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions.

Gynecol Oncol 2007 Mar 5;104(3):670-4. Epub 2006 Dec 5.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.10.010DOI Listing
March 2007

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.

Gynecol Oncol 2007 Feb 4;104(2):435-42. Epub 2006 Oct 4.

Gynecologic Medical Oncology, Department of Medicine, Howard 903, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.08.028DOI Listing
February 2007

Rare uterine cancers.

Lancet Oncol 2005 Dec;6(12):961-71

UP Hematology Associates, Marquette, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(05)70463-0DOI Listing
December 2005

Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.

Gynecol Oncol 2005 Nov 2;99(2):320-6. Epub 2005 Aug 2.

Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-1096, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.06.017DOI Listing
November 2005

Economic outcomes of breast cancer survivorship: CALGB study 79804.

Breast Cancer Res Treat 2005 May;91(2):153-61

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-004-6497-9DOI Listing
May 2005

Cancer screening: how good is good enough?

J Clin Oncol 2004 Oct 20;22(20):4037-9. Epub 2004 Sep 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.06.129DOI Listing
October 2004

Early detection and prognosis of ovarian cancer using serum YKL-40.

J Clin Oncol 2004 Aug;22(16):3330-9

Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Howard 905, 1275 York Ave, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.09.112DOI Listing
August 2004

Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer.

Gynecol Oncol 2004 Apr;93(1):223-8

Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.01.014DOI Listing
April 2004